Advancing Nonclinical Development of PBD-Based ADCs

Time: 2:45 pm
day: Track B - Day 1 - PM

Details:

  • Reviewing Pyrrolobenzadiazepines as warheads for ADCs
  • Addressing challenges in preclinical development of PBD-based payloads when compared to other payloads
  • Assessing the clinical dose setting based on nonclinical data

Speakers: